Regarding the import alert on Ranbaxy’s Toansa Plant
Posted: 24 January 2014 | | No comments yet
Daiichi Sankyo Company Ltd. announced that the US Food and Drug Administration has issued an import alert on January 23 on Active Pharmaceutical Ingredients…
Daiichi Sankyo Company Ltd.(“Daiichi Sankyo”), today announced that the US Food and Drug Administration has issued an import alert on January 23 (US time) on Active Pharmaceutical Ingredients, manufactured at Toansa facility in Punjab, India ,of Ranbaxy Laboratories Limited(“Ranbaxy”).
Daiichi Sankyo is now confirming the situation with Ranbaxy and will announce after getting the more detailed information.
